Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation
NCT07739888
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsNCT Number: NCT06878924
This study is designed to directly compare the safety and efficacy of PFA-based PVI+PWI vs PFA-based PVI+ VoM alcohol ablation in patients with Persistent AF.
Trial opening soon.
Get Notified18 year–85 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Time frame: 1 year
Contact information is provided by the study sponsor or research team.
Texas Cardiac Arrhythmia Research Foundation
Other
Acronym: SAVIOR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739888
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsNCT07740044
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Taizhou, Jiangsu, China
View Trial DetailsNCT07737444
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsNCT07560644
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial Details